Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 06, 2023, titled "Sun Pharma Announces US FDA Filing Acceptance of New Drug Application (NDA) For Deuruxolitinib".
Sun Pharmaceutical Industries Limited Press Release Oct 06 2023
Filed with NSE · · 3 pages · English
Watch Sun Pharmaceutical Industries' latest callSun Pharmaceutical Industries (NSE:SUNPHARMA) Q2 2027 Earnings Call · Replay · Oct 30Read the transcript of Sun Pharmaceutical Industries (NSE:SUNPHARMA) Q2 2027 Earnings CallRelease
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Press Release Sep 27 2023
- Press Release Sep 14 2023
- Press Release Aug 03 2023
- Sun Pharma Announces Health Canada Approval of (PR)ABSORICA LD® (isotretinoin capsules) for Treatment of Severe Nodular Acne
- Press Release Jun 24 2023
Later from Sun Pharmaceutical Industries
- Press Release Oct 12 2023
- Press Release Oct 16 2023
- Press Release Oct 30 2023
- Press Release Nov 01 2023
- Press Release Jan 17 2024
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries